15 September 2016

VAC2VAC project website goes live

VAC2VAC is a wide ranging collaborative research project funded by IMI2 which aims to develop and validate quality testing approaches for both human and veterinary vaccines using non animal methods.  

The initiative  that  started  on  1  March 2016 aims  to  provide  the  data  to  support  the ‘Consistency Approach’ for quality control of established vaccines.  More information on the project and on the participants can now be found under the following link:

09 September 2016

EVI Annual Report 2015 now available

The EVI 2015 Annual Report provides a detailed insight into all of EVI's activities, projects, important meetings etc.  We hope you will find it not only enlightening, but interesting reading.

17 June 2016

EVI moves to new address

As of 15 June 2016 EVI is domiciled at:

European Vaccine Initiative
UniversitätsKlinikum Heidelberg
Vossstrasse 2, Geb. 4040
69115 Heidelberg, Germany

22 May 2016

New publication emerges from the EMVDA project

The following publication relating to the EVI coordinated and EC funded EMVDA project: Immunogenicity of diamorphic and C-terminal fragments of Plasmodium falciparum MSP2 formulated with different adjuvants in mice, was recently published in Vaccine

The abstract is also available on this web site under publications

12 May 2016

A new publication emerges from the MVVC project

The following new publication relating to the EVI coordinated and EDCTP funded MVVC project:  Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African children and infants, has just been published in Mol Ther.

The abstract is also available on this web site under publications

27 January 2016

EVI is currently offering three exciting positions

Three new positions offering exciting challenges to qualified applicants are now available at EVI: 

Senior Project Manager, deadline 15 March 2016
Project Manager, deadline 15 March 2016
Programme Manager Assistant, deadline 15 March 2016

30 December 2015

Postdoc. position in malaria vaccine development at IP

Institut Pasteur currently has a postdoctoral position in malaria vaccine developement.  Applications should be made to Prof. Chetan Chitnis chetan [dot] chitnis [at] pasteur [dot] fr by 15 January 2016

18 December 2015

EVI Rendez-Vous 2015

EVI extends heartfelt thanks to all our donors, colleagues, collaborators, friends and well wishers, whose presence at this annual event, made it a truly memorable occasion.

EVI wishes you a peaceful, restful Xmas, and we hope to see you at next year's Rendez-Vous.


04 December 2015

MultiMalVax Annual Meeting 2015

The MultiMalVax Annual Meeting 2015 was held 17 - 18 November 2015 in Ottignies-Louvain-la-Neuve, Belgium.  With a successful past year the consortium was not only able to discuss the advances in the development of liver-, blood- and mosquito-stage malaria vaccine candidates, but also to look forward to the next stage of the project, which will involve a clinical trial combining the most promising vaccine candidates.

30 October 2015

Search for a placental malaria vaccine leads to breakthrough in cancer research

A placental malaria vaccine research and development project at the Faculty of Medical Health and Science of the University of Copenhagen leads to an encouraging discovery  in the fight against cancer.